LANXESS AG

LXS

Equity

ISIN DE0005470405 / Valor 2046021

Xetra (2025-11-20)

EUR 16.59+3.66%

LANXESS AG
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

LANXESS AG is a leading specialty chemicals company based in Cologne, with a global presence in 32 countries and approximately 12,800 employees. The company's core business involves the development, manufacturing, and marketing of chemical intermediates, additives, and consumer protection products, generating annual sales of EUR 6.7 billion. LANXESS operates through three segments: Advanced Industrial Intermediates, Specialty Additives, and Consumer Protection, encompassing 10 Business Units that cater to various applications and markets. The company prioritizes quality in its products and services, ensuring reliability and efficiency for its customers. LANXESS's global network allows for local service and optimal procurement security, supported by certified process management under international standards like ISO 9001 and ISO 14001.

Summarized from source with an LLMView SourceSector: Industrials

Earnings Surge

In Q3 2024, LANXESS AG's EBITDA pre exceptionals rose by 45.4 percent to EUR 173 million, up from EUR 119 million in the same quarter last year. This growth was primarily fueled by increased production volumes and effective cost management under the “FORWARD!” action plan.

Stable Revenue

Group sales for the third quarter stood at EUR 1.598 billion, nearly matching the prior year's EUR 1.601 billion. While volumes increased across most business units, selling prices experienced a decline due to lower raw material and energy costs.

Improved Profit Margins

The EBITDA margin pre exceptionals improved to 10.8 percent in Q3 2024 from 7.4 percent in the previous year. Net income reached EUR 1 million, a significant turnaround from a net loss of EUR 131 million in the prior-year period.

Full-Year Guidance Reaffirmed

LANXESS AG has maintained its full-year 2024 guidance, expecting EBITDA pre exceptionals to be between 10 and 20 percent higher than the previous year's EUR 512 million. The company anticipates a subdued performance in the fourth quarter due to seasonal factors.

Strategic Divestment

In October, LANXESS agreed to sell its Urethane Systems business to Japan’s UBE Corporation for approximately EUR 500 million. This sale marks the completion of the company's transformation into a specialty chemicals firm and will help reduce debt, pending regulatory approvals expected by mid-2025.

Summarized from source with an LLMView Source

Key figures

-30.4%1Y

-56.9%3Y

-69.5%5Y

Performance

42.5%1Y

39.6%3Y

39.6%5Y

Volatility